Neoplasms, Basal Cell

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Neoplasms

Narrower: Carcinoma, Basosquamous 1

Treatments and conditions

Neoplasms, Basal Cell
Treatment and conditionWhere it standsTrials
Biopsy Procedure + Biospecimen Collection + Computed Tomography + Laboratory Biomarker Analysis + Positron Emission Mammography + TALIMOGENE LAHERPAREPVEC + NIVOLUMAB for carcinoma, basosquamousPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Gemcitabine + ERLOTINIB + NAB-PACLITAXEL for neoplasms, basal cellPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.